Schonfeld Strategic Advisors’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-31,751
Closed -$46K – 2989
2026
Q1
$46K Buy
+31,751
New +$50.3K ﹤0.01% 1982
2025
Q2
– Sell
-14,209
Closed -$52.3K – 2518
2025
Q1
$52.3K Buy
+14,209
New +$51.9K ﹤0.01% 2068
2023
Q1
– Sell
-14,000
Closed -$96.2K – 2624
2022
Q4
$96.2K Buy
+14,000
New +$66.1K ﹤0.01% 2193

Other funds holding STIM

Schonfeld Strategic Advisors's STIM Position: Q2 2026 in Review

Schonfeld Strategic Advisors sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 31,751 shares — an estimated $46K sold.

Schonfeld Strategic Advisors first reported a position in STIM in Q4 2022 and held it in 3 quarters. The position peaked at $96.2K in Q4 2022. 86 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Schonfeld Strategic Advisors reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 31,751 Neuronetics shares in Q2 2026, an estimated $46K.
  • Schonfeld Strategic Advisors first reported a position in Neuronetics in Q4 2022 and held it in 3 quarters.
  • Schonfeld Strategic Advisors's Neuronetics position peaked at $96.2K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.